CD4 +CD25 + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients.
about
Myeloid suppressor cells and immune modulation in lung cancerAdoptive immunotherapy with interleukin-2 & induced killer cells in non-small cell lung cancer: A systematic review & meta-analysisHow regulatory T cells workDendritic cells decreased the concomitant expanded Tregs and Tregs related IL-35 in cytokine-induced killer cells and increased their cytotoxicity against leukemia cells.Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors.Sunitinib indirectly enhanced anti-tumor cytotoxicity of cytokine-induced killer cells and CD3⁺CD56⁺ subset through the co-culturing dendritic cells.Cisplatin pretreatment enhances anti-tumor activity of cytokine-induced killer cells.Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer.The therapeutic effect of cytokine-induced killer cells on pancreatic cancer enhanced by dendritic cells pulsed with K-ras mutant peptideCytokine-induced killer cells combined with dendritic cells inhibited liver cancer cellsThe combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors.Effects of CpG Oligodeoxynucleotide 1826 on transforming growth factor-beta 1 and radiation-induced pulmonary fibrosis in miceHow to detour Treg cells in T cell-based antitumor immune therapy.Targeting regulatory T cells in cytokine-induced killer cell cultures (Review).Cytokine induced killer cells as promising immunotherapy for solid tumors.Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.Clinical studies applying cytokine-induced killer cells for the treatment of renal cell carcinoma.Adoptive immunotherapy strategies with cytokine-induced killer (CIK) cells in the treatment of hematological malignanciesCytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectives.Comparison of the proliferation, cytotoxic activity and cytokine secretion function of cascade primed immune cells and cytokine-induced killer cells in vitroPreconditioning chemotherapy with paclitaxel and cisplatin enhances the antitumor activity of cytokine induced-killer cells in a murine lung carcinoma model.Human cytokine-induced killer cells specifically infiltrated and retarded the growth of the inoculated human cholangiocarcinoma cells in SCID mice.Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells.Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study.Regulatory T cells in the actinic cheilitis.Anticancer cellular immunotherapies derived from umbilical cord blood.The possible molecular regulation mechanism of CIK cells inhibiting the proliferation of Human Lung Adenocarcinoma NCL-H157 Cells.Primitive neuroectodermal tumor of the kidney at the advanced stage: A case series of eight Chinese patients.
P2860
Q26823251-A245C975-E738-42F1-9F35-EF488435B65DQ28072200-A37A4F82-2C42-4019-A680-99C67A753AFCQ29614262-03299F50-2545-4D0B-BDE8-17435DF80AB0Q31157715-470496C1-4FAA-4502-96FA-0A16AD368EC0Q34635795-5A2C226D-A7AC-478D-95C9-E94B7F0D6F08Q35043102-4F6A444E-B329-4ED7-9561-19F4D3FFAB6CQ35093618-9A2C0AFA-87ED-4943-AA5B-FE9B3150AD04Q35655447-40AB495F-9E2B-4AEA-8DA2-11C44FA48C5FQ35755295-0FDC89CA-C4FF-4D6B-81EC-A2B5A8A05088Q35791951-344781BC-3BC4-4312-8FFB-8CC4479912F6Q36270334-F55F6E8B-E5AA-47A0-8E1C-A92D833B2CD1Q36907395-8B96C28B-B0C7-4B70-B90F-28CE3DEB6402Q37169964-5EF7BDCC-FD07-4BBD-B3D0-62BCE91A269AQ37708451-4D0AB798-39B5-49FB-85AC-75BA1A74A1B0Q37895924-D4ADB867-0B2C-4DC5-B458-6B3EB5D61990Q38002494-C961843A-28C9-40AB-A11D-6FD4896C16DCQ38063500-00E6E2E1-0058-4FCD-AB12-E9337144385CQ38246720-16832237-6953-4E6A-930B-271A6E5B0286Q38574526-91BFE856-81D0-48E1-807E-F4EEDE11D386Q38877731-A1DEBAB3-9B24-48DD-8A33-E73B4D39F04BQ39650152-14A07960-4EFD-459E-B4E5-EBE6E13EDF63Q39880803-37FF364A-5CCC-4D80-A7F0-B6F6B52F201BQ42274903-C4D920F7-6ACE-4C1E-9E6F-154B8C3026FBQ45246341-A491FEE1-92D9-4379-BF62-007597DBF557Q46002993-3446BEC2-66EE-4284-8383-A68642BDA7CEQ47657491-7BFFB6B5-2E46-4978-8748-FD6EC40034A1Q53888373-33E76266-EE56-4843-B555-5CFA00796974Q54967107-891A8FEE-5C70-493C-A6E5-2EFA374EEE7D
P2860
CD4 +CD25 + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
CD4 +CD25 + regulatory T cells ...... cells of lung cancer patients.
@ast
CD4 +CD25 + regulatory T cells ...... cells of lung cancer patients.
@en
CD4 +CD25 + regulatory T cells ...... ity of cytokine-induced killer
@nl
type
label
CD4 +CD25 + regulatory T cells ...... cells of lung cancer patients.
@ast
CD4 +CD25 + regulatory T cells ...... cells of lung cancer patients.
@en
CD4 +CD25 + regulatory T cells ...... ity of cytokine-induced killer
@nl
prefLabel
CD4 +CD25 + regulatory T cells ...... cells of lung cancer patients.
@ast
CD4 +CD25 + regulatory T cells ...... cells of lung cancer patients.
@en
CD4 +CD25 + regulatory T cells ...... ity of cytokine-induced killer
@nl
P2093
P2860
P1476
CD4 +CD25 + regulatory T cells ...... cells of lung cancer patients.
@en
P2093
Peng Zhang
Xiu-Bao Ren
Xiu-Mei An
Zong-Tang Huang
P2860
P2888
P304
P356
10.1007/S10875-007-9076-0
P577
2007-04-28T00:00:00Z
P6179
1050401227